Together is a new resource for anyone affected by pediatric cancer - patients and their parents, family members, and friends.Learn More
Sunitinib is a type of medicine called a targeted therapy. This medicine is a tyrosine kinase inhibitor or vascular endothelial growth factor (VEGF) inhibitor. It acts to block certain cell signals to help keep cells from growing. It can also help block the growth of blood vessels that supply oxygen to tumors.
Patients will have regular blood draws to check blood counts and monitor liver, kidney, and thyroid function. Blood pressure and heart function may also be monitored. The dose of sunitinib may change based on results of lab tests.
May be taken as a capsule by mouth
Not all patients who take sunitinib will experience these side effects. Common side effects are in bold, but there may be others. Please report all suspected side effects to your doctor or pharmacist.
Some patients may experience long-term or late effects of treatment that may continue or develop months or years after treatment ends. Possible late effects due to sunitinib include:
Be sure to discuss these and other recommendations with your doctor or pharmacist.